Scott Rocklage is a doctor with extensive experience in the healthcare management industry. In fact, he has over 30 years of experience. Below is more information about his career at 4AM Ventures, and elsewhere. Information about his education and achievements will also be discussed.
Scott Rocklage’s Career
Rocklage serves as a Managing Partner at 5AM Ventures. He has held the position since 2004, and prior to that he was the company’s Venture Partner. He served as Venture Partner for a year. Prior to becoming a partner at 5AM Ventures, Rocklage was the CEO of Cubist Pharmaceuticals. He was also the CEO and President of Nycomed Salutar. Read more: Scott Racklage | Crunchbase
He sits on several boards of prominent companies such as Kinestral, Rennovia and Cidara. Other boards he sits on includes Pulmatrix and Epirus. In the past, he has sat on Novira’s board and Relypsa’s board.
Rocklage attended college at the University of California. He earned his bachelor’s in chemistry, as well as his Ph.D in chemistry from MIT. He also worked under the guidance of Richard Schrock. Rocklage conducted research in Schrock’s laboratory.
He has invented or co-invented dozens of patents in the United States. Not only that, but he has over 50 peer-reviewed publications. He has also played a role in the approval of three new drug applications in the United States.
Dr. Scott Rocklage has done a great job at 5AM Ventures, as well as at the other companies he has worked for. As you can see, he is highly educated and is a smart businessman and worker.
Learn more about Scott Rocklage: